Blepharospasm clinical trials
The registry lists 42 studies for Blepharospasm across more than 10 countries. 1 are recruiting or about to start. 27 of them are mainly about Blepharospasm (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-29.
Get an email when these change. Save the Blepharospasm studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
National Institute of Neurological Disorders and Stroke (NINDS) (8) · Allergan (4) · Merz Pharmaceuticals GmbH (4) · Second Affiliated Hospital, School of Medicine, Zhejiang University (2) · Ipsen (2) · Daewoong Pharmaceutical Co. LTD. (1) · China Academy of Chinese Medical Sciences (1) · Xinhua Hospital, Shanghai Jiao Tong University School of Medicine (1)
What is being tested here
Drugs under test in Blepharospasm studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Who these studies take
Of the 1 Blepharospasm studies recruiting now, 1 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 1 (100%) | 1 (100%) |
| 30 | 1 (100%) | 1 (100%) |
| 40 | 1 (100%) | 1 (100%) |
| 50 | 1 (100%) | 1 (100%) |
| 65 | 1 (100%) | 1 (100%) |
| 75 | 1 (100%) | 1 (100%) |
| 85 | 1 (100%) | 1 (100%) |
Across all 42 studies, recruiting or not: 10% stop at 75 or younger and 0% at 65; 21% take children; 0% are for women only and 0% for men only; 19% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 42 of 42. search them.
- DaxibotulinumtoxinA for BlepharospasmRecruitingNCT07489430Phase 21 country
- Analysis of Gait Before and After Botulinum Toxin Treatment in Patients With Focal DystoniaCompletedNCT03938363Not applicable1 country
- Exploratory Study of Dipraglurant (ADX48621) for the Treatment of Patients With BlepharospasmCompletedNCT05027997Phase 21 country
- Effect of Topical Botulinum Toxin Eyedrop on Palpebral FissureTerminatedNCT06080438Phase 41 country
- Safety and Efficacy of Pluripotent Stem Cell-derived Mesenchymal Stem Cell Exosome (PSC-MSC-Exo) Eye Drops Treatment for Dry Eye Diseases Post Refractive Surgery and Associated With BlepharospasmStatus unknownNCT05738629Phase 1/21 country
- Wumeiwan Jiawei Fang Use in Patients With BlepharospasmStatus unknownNCT05618470Phase 2/31 country
- Blepharospasm Patient Survey for Patients With BlepharospasmCompletedNCT016860611 country
- Botulinum Toxin Relieves Anxiety, Depression and Sleep Disorderes in Patients With BlepharospasmStatus unknownNCT04939909Early Phase 11 country
- Efficacy and Safety of 10-Week or Shorter vs 12-Week or Longer Injection Intervals of Botulinum ToxinCompletedNCT051032021 country
- An RCT of a Patient-initiated Treatment Service for BEB and HFSCompletedNCT02577224Not applicable1 country
- Effect of Non-psychoactive Cannabidiol as an Adjunct to Botulinum Toxin in BlepharospasmCompletedNCT04423341Phase 2/31 country
- A Comparative Study of GPI's DBS and Pallidotomy in the Treatment of Meige SyndromeStatus unknownNCT046188871 country
- Post Marketing Surveillance Study of DysportCompletedNCT002104313 countries
- Brain Changes in BlepharospasmTerminatedNCT004873831 country
- Study of a Single Administration of 3 Doses of Dysport® for the Treatment of Benign Essential BlepharospasmCompletedNCT00234507Phase 21 country
- Safety and Efficacy of NABOTA in Treatment of Essential BlepharospasmCompletedNCT02947815Phase 2/31 country
- Blepharospasm ToolsCompletedNCT027803364 countries
- Pretarsal Versus Preseptal Botulinum Toxin for Patients With Eyelid SpasmCompletedNCT03508882Phase 4
- Photic Blink Reflex in People With Blepharospasm and Increased BlinkingTerminatedNCT032630001 country
- Deep Brain Stimulation in Patients With DystoniaCompletedNCT00773604Not applicable1 country
- HLA Screening in Reducing the Risk of Antiepileptic Drug-induced Cutaneous Adverse ReactionsStatus unknownNCT03184597Not applicable1 country
- Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Abnormal Contraction or Twitch of the EyelidCompletedNCT01896895Phase 33 countries
- A Mechanical Device for BlepharospasmCompletedNCT03269123Not applicable
- Neurophysiological Markers in Patients With Craniofacial Dystonia and Their RelativesCompletedNCT000826151 country
- Brain Changes in BlepharospasmCompletedNCT005007991 country
- Brain Stimulation to Treat Blepharospasm or Meige SyndromeCompletedNCT00411255Phase 21 country
- Acetyl Hexapeptide-8 for BlepharospasmTerminatedNCT01750346Phase 21 country
- Two Different Surgical Methods of BlepharospasmStatus unknownNCT02765113Early Phase 1
- A Retrospective Chart Review of BOTOX® and Xeomin® for the Management of Cervical Dystonia and BlepharospasmCompletedNCT022459582 countries
- Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United StatesCompletedNCT012872471 country
- Comparison of Different Botulinum Toxin A Injection Patterns in the Treatment of BlepharospasmStatus unknownNCT02327728Not applicable1 country
- MDs on Botox Utility (MOBILITY)CompletedNCT005359381 country
- A Retrospective Chart Review of BOTOX® and Xeomin® for the Treatment of Cervical Dystonia and BlepharospasmCompletedNCT018147742 countries
- Comparison of Two Botulinum Type A Products in the Treatment of BlepharospasmCompletedNCT00761592Phase 41 country
- IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of BlepharospasmCompletedNCT00406367Phase 32 countries
- A Study of Acetyl Hexapeptide-8 (AH8) in Treatment of BlepharospasmCompletedNCT00942851Phase 1/21 country
- Efficacy of Aurosling in Frontalis Sling Suspension SurgeryCompletedNCT00753831Phase 41 country
- Testing the Effect of Zinc Supplementation to Improve the Treatment Effect of Botulinum Toxin for Oculofacial SpasmStatus unknownNCT01546805Not applicable1 country
- Blepharospasm Short IntervalTerminatedNCT00507637Phase 21 country
- Movement Disorder Survey in East ChinaCompletedNCT011683881 country
- Comparison of Korean Botulinum Toxin Type A Versus Botox in the Treatment of Essential BlepharospasmCompletedNCT00682760Phase 31 country
- Mexiletine for the Treatment of Focal DystoniaCompletedNCT00001784Phase 21 country